Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors.

Watanabe K, Tajino T, Sekiguchi M, Suzuki T.

Am J Clin Pathol. 2000 May;113(5):663-8.

PMID:
10800398
2.

Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.

Ceballos KM, Nielsen GP, Selig MK, O'Connell JX.

Am J Clin Pathol. 2000 Nov;114(5):746-53.

PMID:
11068549
3.

h-Caldesmon as a specific marker of smooth muscle cell differentiation in some soft tissue tumors of the skin.

D'Addario SF, Morgan M, Talley L, Smoller BR.

J Cutan Pathol. 2002 Aug;29(7):426-9.

PMID:
12139638
4.
5.

Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.

Sakamoto A, Oda Y, Yamamoto H, Oshiro Y, Miyajima K, Itakura E, Tamiya S, Honda Y, Ishihara A, Iwamoto Y, Tsuneyoshi M.

Virchows Arch. 2002 Apr;440(4):404-9. Epub 2001 Nov 7.

PMID:
11956822
6.
8.
9.

Expression of smooth muscle markers in so called malignant fibrous histiocytomas.

Hasegawa T, Hasegawa F, Hirose T, Sano T, Matsuno Y.

J Clin Pathol. 2003 Sep;56(9):666-71.

10.

A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors.

Lee CH, Turbin DA, Sung YC, Espinosa I, Montgomery K, van de Rijn M, Gilks CB.

Mod Pathol. 2009 Dec;22(12):1519-31. doi: 10.1038/modpathol.2009.122. Epub 2009 Sep 4.

11.

h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.

Nucci MR, O'Connell JT, Huettner PC, Cviko A, Sun D, Quade BJ.

Am J Surg Pathol. 2001 Apr;25(4):455-63.

PMID:
11257619
12.

Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.

Oda Y, Miyajima K, Kawaguchi K, Tamiya S, Oshiro Y, Hachitanda Y, Oya M, Iwamoto Y, Tsuneyoshi M.

Am J Surg Pathol. 2001 Aug;25(8):1030-8.

PMID:
11474287
13.
14.

Smooth and skeletal muscle myosins in spindle cell tumors of soft tissue. An immunohistochemical study.

Saku T, Tsuda N, Anami M, Okabe H.

Acta Pathol Jpn. 1985 Jan;35(1):125-36.

PMID:
2988265
15.

Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.

Coco DP, Hirsch MS, Hornick JL.

Am J Surg Pathol. 2009 Dec;33(12):1795-801.

PMID:
19950405
16.

Potential utility of CD5 immunohistochemical staining in the diagnosis of muscle tumors.

McNab PM, DeMers NM, Schlauder S, Morgan M, Nasir A, Coppola D, Bui MM.

Ann Clin Lab Sci. 2009 Spring;39(2):108-13.

PMID:
19429795
17.

[Immunohistochemical differentiation of leiomyocellular tumors and tumors with myogenic differentiation].

Povýsil C, Ciprová V, Dundr P, Horáková M.

Cesk Patol. 2003 Apr;39(2):64-8. Czech.

PMID:
12874903
18.

Primary bone tumors. MR morphologic appearance correlated with pathologic examinations.

Golfieri R, Baddeley H, Pringle JS, Leung AW, Greco A, Souhami R, Kemp H.

Acta Radiol. 1991 Jul;32(4):290-8.

PMID:
1650569
20.

Immunophenotypic heterogeneity in osteosarcomas.

Hasegawa T, Hirose T, Kudo E, Hizawa K, Usui M, Ishii S.

Hum Pathol. 1991 Jun;22(6):583-90.

PMID:
1864588

Supplemental Content

Support Center